Supply disruption: Olanzapine Orodispersible (Zypine ODT) 10mg and 5mg tablets
- 3 days ago
- 2 min read
There is currently a supply issue affecting olanzapine orodispersible 10 mg and 5 mg tablets (Zypine ODT). This is due to an unexpected issue at the manufacturing site.
To ensure people can continue their treatment without interruption, alternative products are being funded from 1 May 2026. All alternative products are not approved by Medsafe and therefore subject to Section 29A of the Medicines Act.
Key information:
| Registered Product 5mg
Olanzapine orodispersible 5mg tablets | Alternate Products 5mg – Section 29 Olanzapine orodispersible 5mg tablet | Registered Product 10mg
Olanzapine orodispersible 10mg tablets | Alternate Products 10mg -Section 29 Olanzapine orodispersible 10mg tablet
|
Brand | Zypine ODT
| APO-Olanzapine | Zypine ODT
| APO-Olanzapine |
Availability | Stock expected to run out late May 2026.
Resupply date TBC
| Will be listed on the Schedule 1 May 2026
| Currently supplying S29A alternatives
Resupply date TBC
| Will be listed on the Schedule 1 May 2026
|
Second alternate product |
| Olanzapine ODT Viatris has also been listed; however, this brand is not yet available. If this changes, we will update our webpage accordingly.
|
| Olanzapine ODT Viatris has also been listed; however, this brand is not yet available. If this changes, we will update our webpage accordingly.
|
Further information is available on our webpage and will be updated as information becomes available – Olanzapine (Zypine ODT) 10mg and 5mg orodispersible tablets: Supply issue.
Please share this information:
Please share this information with your colleagues and within your networks.
If you have any questions regarding this supply issue, please contact enquiry@pharmac.govt.nz.
Ngā mihi
Dr David Hughes
David Hughes
Chief Medical Officer | Director Advice & Assessment
________________________________________________________________________________
Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
DDI: +64 21 962 317 | P: +64 4 460 4990 | www.pharmac.govt.nz